Home > Compound List > Product Information
4-(tert-Butyldimethylsilyloxy)phenylboronic acid_Molecular_structure_CAS_159191-56-7)
Click picture or here to close

4-(tert-Butyldimethylsilyloxy)phenylboronic acid

Catalog No. 524042 Name Sigma Aldrich
CAS Number 159191-56-7 Website http://www.sigmaaldrich.com
M. F. C12H21BO3Si Telephone 1-800-521-8956
M. W. 252.18984 Fax
Purity ≥95% Email
Storage Chembase ID: 78729

SYNONYMS

Title
4-(叔丁基二甲基硅氧基)苯基硼酸
IUPAC name
{4-[(tert-butyldimethylsilyl)oxy]phenyl}boronic acid
IUPAC Traditional name
4-[(tert-butyldimethylsilyl)oxy]phenylboronic acid
Synonyms
4-(tert-Butyldimethylsilyloxy)benzeneboronic acid

DATABASE IDS

PubChem SID 24874387
MDL Number MFCD03093888
CAS Number 159191-56-7

PROPERTIES

Linear Formula (CH3)3CSi(CH3)2OC6H4B(OH)2
Purity ≥95%
Melting Point 194-198 °C(lit.)
MSDS Link Download
Personal Protective Equipment Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter
German water hazard class 3

DETAILS

Description (English)
Packaging
1, 5 g in glass bottle
Application
Reactant involved in:
• Asymmetric addition reactions with β-substituted cyclic enones1
• Hydroarylation and heterocyclization with phenylpropiolates2
• Double Suzuki-Miyaura coupling reactions3Starting material for the synthesis of red electroluminescent polyfluorenes4Reactant involved in the synthesis of biologically active molecules including:
• Phenylpyridone derivatives as MCH1R antagonists5
• Atromentin and its O-alkylated derivatives3
• Gelatinases and MT1-MMP inhibitors6
Description (简体中文)
包装
1, 5 g in glass bottle
Application
Reactant involved in:
• Asymmetric addition reactions with β-substituted cyclic enones1
• Hydroarylation and heterocyclization with phenylpropiolates2
• Double Suzuki-Miyaura coupling reactions3Starting material for the synthesis of red electroluminescent polyfluorenes4Reactant involved in the synthesis of biologically active molecules including:
• Phenylpyridone derivatives as MCH1R antagonists5
• Atromentin and its O-alkylated derivatives3
• Gelatinases and MT1-MMP inhibitors6

REFERENCES